Scandal Resurfaces,Confidence Down

• 来源期刊: 中国外经贸（英文版）
• 年，卷（期）: 2006,（6）
• 页码范围: 46
• 页数: 1页
• 语种: 英文

摘要

The news that Shanghai Worldbest Pharmaceutical Co inflated earnings and sales between 2001 and 2004 has marred the bullish stock market and cautioned investors in Chinese mainland-listed shares.Shanghai Worldbest, a medicine unit of China's State-owned textile and pharmaceutical conglomerate, said in a statement that it used inaccurate data to inflate profit by 65.11 million yuan (US$8.1 million) from 2001 to 2004.